Safety and immunogenicity of Vi-diphtheria toxoid typhoid conjugate vaccine among children below 2 years: a systematic review and meta-analysis

A Mohamed Taha, K Abouelmagd… - Frontiers in …, 2024 - frontiersin.org
Background The Vi-diphtheria toxoid typhoid conjugate vaccine (Vi-DT) has shown
promising results in preventing typhoid fever in children under 2 years of age. However, a …

Salmonella Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses

LC Dahora, MK Verheul, KL Williams, C Jin… - Science …, 2021 - science.org
Vaccine development to prevent Salmonella Typhi infections has accelerated over the past
decade, resulting in licensure of new vaccines, which use the Vi polysaccharide (Vi PS) of …

A phase 3, multicenter, randomized, controlled trial to evaluate immune equivalence and safety of multidose and single-dose formulations of vi-DT typhoid conjugate …

JC Carlos, BT Tadesse, C Borja-Tabora… - The Lancet Regional …, 2022 - thelancet.com
Summary Trial Design Phase 3, randomized, controlled, multicenter, equivalence trial.
Methods Recruitment of participants occurred between 04Februray2020 and 15July2020 at …

Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity

S Chakraborty, P Dutta, A Pal, S Chakraborty, G Banik… - npj Vaccines, 2024 - nature.com
Abstract Development of safe, highly effective and affordable enteric fever vaccines is a
global health priority. Live, oral typhoid vaccines induce strong mucosal immunity and long …

Intranasal Immunization of Mice with a Chimeric Antigen of Cholera Toxin B and Salmonella Typhi outer membrane protein T2544 elicits protective antibodies and T …

S Chakraborty, P Dutta, A Pal, S Chakraborty, G Banik… - 2023 - researchsquare.com
Abstract Development of safe, highly effective and affordable enteric fever vaccines is a
global health priority. Live, oral typhoid vaccines induce strong mucosal immunity and long …

Antisalmonella Activity and Modes of Action of Extracts, Fractions and Cerevisterol from Impatiens burtonii against Multi-Drug Resistant Salmonella

ADY Piankeu, FWT Kenmoe… - Microbiology …, 2024 - archive.article4submit.com
Background: Typhoid fever is an endemic disease in developing countries, especially
throughout Asia and Africa, which may lead to life-threatening conditions in the absence of …

Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose

MR Capeding, BT Tadesse, A Sil, E Alberto, DR Kim… - npj Vaccines, 2022 - nature.com
Vaccination with typhoid conjugate vaccines (TCV) is a major part of typhoid prevention.
However, little is known about long-term immune persistence following vaccination with …

Investigating novel mechanisms of immunity against enteric fever

M Johnson - 2022 - ora.ox.ac.uk
Approximately 14.9 million cases of enteric fever are caused by Salmonella enterica serovar
Typhi (S. Typhi) and S. Paratyphi, with several strains becoming resis-tant to frontline …

[PDF][PDF] Amira Mohamed Taha, Khaled Abouelmagd 2, Abdelrahman Mohamed Mahmoud 3, Mohamed Hamouda Elkasaby 4, Dang Nguyen 5, Ryan Ahmed 6, Pari …

R Ahmed - 2024 - pdfs.semanticscholar.org
Background: The Vi-diphtheria toxoid typhoid conjugate vaccine (Vi-DT) has shown
promising results in preventing typhoid fever in children under 2 years of age. However, a …